INVESTOR ALERT: Investigation of Insys Therapeutics Announced by Holzer & Holzer

ATLANTA--()--On December 8, 2016, six former executives of Insys Therapeutics, Inc. (“Insys” or the “Company”) (NASDAQ: INSY) were arrested and charged with bribing doctors to unnecessarily prescribe a drug containing Fentanyl. The Department of Justice accuses certain former executives of providing doctors with illegal kick-backs from June 2012 to December 2015. Holzer & Holzer, LLC is investigating whether the board of directors complied with its fiduciary duties during that time.

If you have held Insys stock since at least June 2012 and wish to learn more about this investigation, you are encouraged to contact Corey D. Holzer, Esq. via email (cholzer@holzerlaw.com) or via toll-free telephone at (888) 508-6832 to discuss your legal rights.

Holzer & Holzer, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. More information about the firm is available through its website, www.holzerlaw.com and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey D. Holzer is the attorney responsible for its content.

Contacts

Holzer & Holzer, LLC
Corey D. Holzer, Esq.
Toll-free: 888-508-6832
cholzer@holzerlaw.com

Release Summary

Holzer investigates Insys Therapeutics.

Contacts

Holzer & Holzer, LLC
Corey D. Holzer, Esq.
Toll-free: 888-508-6832
cholzer@holzerlaw.com